Prothrombin Complex Concentrate Market Size, Share, and Analysis, By Product (3-Factor PCC, 4-Factor PCC), By Application (Congenital Coagulation Factor Deficiency, Acquired Coagulation Factor Deficiency), By End-Use (Hospitals, Ambulatory Surgical Centres, Specialty Clinics and Others) and Regional Forecasts, 2022-2032
Prothrombin Complex Concentrate Market Size, Share, and Analysis, By Product (3-Factor PCC, 4-Factor PCC), By Application (Congenital Coagulation Factor Deficiency, Acquired Coagulation Factor Deficiency), By End-Use (Hospitals, Ambulatory Surgical Centres, Specialty Clinics and Others) and Regional Forecasts, 2022-2032
PRODUCT OVERVIEW:
Prothrombin Complex Concentrate (PCC) is als%li%known as factor lX complex, which is a medicament created using blood clotting factors ll, lX, and X which helps in the treatment of bleeding disorders. Few versions of PCC even contain factor Vll. PCC is obtained from human plasma and contains concentrated coagulation factors. It is utilized t%li%resolve and prevent bleeding in haemophilia B and is used in insufficiency of these components due t%li%warfarin treatment etc. It is incorporated int%li%the body using a syringe int%li%vein. By administering through IV, PCC refillls the coagulation factors in the blood immediately.
MARKET HIGHLIGHTS
Prothrombin Complex Concentrate Market is expected t%li%project a CAGR of 10.4% during the forecast period, 2022-2032
Prothrombin Complex Concentrate Market is expected t%li%reach USD 2153.2 million, growing at a CAGR of 10.4% during forecast period. Prothrombin Complex Concentrate (PCC) is anticipated t%li%increase due t%li%the presence of several clinical advantages over fresh frozen plasma (FPP). PCC take less volume and time t%li%infuse compared with FPP and is efficient. PCC has n%li%requirement for blood matching and thawing which increases the preference and demand for PCC market growth. The relaxation of government regulations and policies have created positive impact for the growth of the PCC market.
PROTHROMBIN COMPLEX CONCENTRATE MARKET SEGMENTATION:
3-Factor PCC segment is expected t%li%grow with high CAGR during the forecast period
Prothrombin Complex Concentrate Market is classified based on the Product int%li%3-Factor PCC, 4-Factor PCC. The 4-factor segment dominated the market in 2021 owing t%li%the enhanced penetration of 4-factor PCC in developing countries and their efficacy for warfarin reversal which helped t%li%boost the growth of the market. The government initiatives t%li%reduce adverse events related t%li%warfarin is anticipated t%li%boost the growth of segment. The 3-factor segment is expected t%li%dominate the market in the forecast period owing t%li%the increasing prevalence of haemophilia and growing demand for plasma products which is expected t%li%drive the segment growth.
Specialty clinics segment are expected t%li%grow with high CAGR during the forecast period
Prothrombin Complex Concentrate Market is classified based on the End-Use int%li%Hospitals, Ambulatory Surgical Centres, Specialty Clinics and Others. The hospitals segment dominated the market in 2021 owing t%li%the increasing preference for prothrombin complex concentrate, favourable government initiatives, and increased obtaining of plasma products. Specialty clinics segment is anticipated t%li%grow in forecast period due t%li%the growing surgeons and increasing number of privately-owned clinics.
MARKET DYNAMICS:
Growth Drivers
Growing Haemophilia B Issues is Expected t%li%Boost the Growth of the Market
Advantages of Prothrombin Complex Concentrate May Boost the Market Growth
Restraint
High Procurement Cost May Restrain the Growth of the Market
PROTHROMBIN COMPLEX CONCENTRATE MARKET
Key Players Covered:
PRODUCT OVERVIEW:
Prothrombin Complex Concentrate (PCC) is als%li%known as factor lX complex, which is a medicament created using blood clotting factors ll, lX, and X which helps in the treatment of bleeding disorders. Few versions of PCC even contain factor Vll. PCC is obtained from human plasma and contains concentrated coagulation factors. It is utilized t%li%resolve and prevent bleeding in haemophilia B and is used in insufficiency of these components due t%li%warfarin treatment etc. It is incorporated int%li%the body using a syringe int%li%vein. By administering through IV, PCC refillls the coagulation factors in the blood immediately.
MARKET HIGHLIGHTS
Prothrombin Complex Concentrate Market is expected t%li%project a CAGR of 10.4% during the forecast period, 2022-2032
Prothrombin Complex Concentrate Market is expected t%li%reach USD 2153.2 million, growing at a CAGR of 10.4% during forecast period. Prothrombin Complex Concentrate (PCC) is anticipated t%li%increase due t%li%the presence of several clinical advantages over fresh frozen plasma (FPP). PCC take less volume and time t%li%infuse compared with FPP and is efficient. PCC has n%li%requirement for blood matching and thawing which increases the preference and demand for PCC market growth. The relaxation of government regulations and policies have created positive impact for the growth of the PCC market.
PROTHROMBIN COMPLEX CONCENTRATE MARKET SEGMENTATION:
3-Factor PCC segment is expected t%li%grow with high CAGR during the forecast period
Prothrombin Complex Concentrate Market is classified based on the Product int%li%3-Factor PCC, 4-Factor PCC. The 4-factor segment dominated the market in 2021 owing t%li%the enhanced penetration of 4-factor PCC in developing countries and their efficacy for warfarin reversal which helped t%li%boost the growth of the market. The government initiatives t%li%reduce adverse events related t%li%warfarin is anticipated t%li%boost the growth of segment. The 3-factor segment is expected t%li%dominate the market in the forecast period owing t%li%the increasing prevalence of haemophilia and growing demand for plasma products which is expected t%li%drive the segment growth.
Specialty clinics segment are expected t%li%grow with high CAGR during the forecast period
Prothrombin Complex Concentrate Market is classified based on the End-Use int%li%Hospitals, Ambulatory Surgical Centres, Specialty Clinics and Others. The hospitals segment dominated the market in 2021 owing t%li%the increasing preference for prothrombin complex concentrate, favourable government initiatives, and increased obtaining of plasma products. Specialty clinics segment is anticipated t%li%grow in forecast period due t%li%the growing surgeons and increasing number of privately-owned clinics.
MARKET DYNAMICS:
Growth Drivers
Growing Haemophilia B Issues is Expected t%li%Boost the Growth of the Market
Advantages of Prothrombin Complex Concentrate May Boost the Market Growth
Restraint
High Procurement Cost May Restrain the Growth of the Market
PROTHROMBIN COMPLEX CONCENTRATE MARKET
Key Players Covered:
- Octapharma AG
- Grifols S.A.
- Nov%li%Nordisk
- CSL Behring GmbH
- Kedrion Biopharma Inc.
- China Biologic Products Holdings, Inc.
- Shire Plc
- Sanquin
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- Reasons t%li%Purchase this Report
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight int%li%the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1. Regional Market Share
1.2.Business Trends
1.3.Prothrombin Complex Concentrate Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1.Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4.Primary Research
2.5.Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1.Market Definition
3.2.Prothrombin Complex Concentrate Market: COVID-19 Impact
3.3. Key Segmentations
3.4.Key Developments
3.5.Allied Industry Data
4. PROTHROMBIN COMPLEX CONCENTRATE MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2.COVID-19 overview on world economy
4.3.Industry ecosystem Channel analysis
4.4.Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7. MARKET DYNAMICS
7.1.Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4.Market Restraints
7.5. Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1.Porters Five Forces
9.2. PEST Analysis
9.2.1.Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10.PROTHROMBIN COMPLEX CONCENTRATE MARKET
10.1.Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2.Key Findings
11.3.Market Segmentation
11.3.1. By Product
11.3.1.1. 3-Factor PCC
11.3.1.1.1.By Value (USD Million) 2022-2032F
11.3.1.1.2. Market Share (%) 2022-2032F
11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.2.4-Factor PCC
11.3.1.2.1. By Value (USD Million) 2022-2032F
11.3.1.2.2.Market Share (%) 2022-2032F
11.3.1.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2. By Application
11.3.2.1.Congenital Coagulation Factor Deficiency
11.3.2.1.1. By Value (USD Million) 2022-2032F
11.3.2.1.2.Market Share (%) 2022-2032F
11.3.2.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Acquired Coagulation Factor Deficiency
11.3.2.2.1.By Value (USD Million) 2022-2032F
11.3.2.2.2. Market Share (%) 2022-2032F
11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.By End-Use
11.3.3.1.Hospitals
11.3.3.1.1. By Value (USD Million) 2022-2032F
11.3.3.1.2.Market Share (%) 2022-2032F
11.3.3.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Ambulatory Surgical Centres
11.3.3.2.1.By Value (USD Million) 2022-2032F
11.3.3.2.2. Market Share (%) 2022-2032F
11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Specialty Clinics
11.3.3.3.1.By Value (USD Million) 2022-2032F
11.3.3.3.2. Market Share (%) 2022-2032F
11.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.4. Others
11.3.3.4.1.By Value (USD Million) 2022-2032F
11.3.3.4.2. Market Share (%) 2022-2032F
11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
12.NORTH AMERICA PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE & FORECAST 2022A-2032F
12.1.Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product
12.3.2.By Application
12.3.3.By End Use
12.4. Country
12.4.1. United States
12.4.2.Canada
13.EUROPE PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE & FORECAST 2022A-2032F
13.1.Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1.By Product
13.3.2.By Application
13.3.3.By End Use
13.4.Country
13.4.1. Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4.Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14.ASIA PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3.Market Segmentation
14.3.1.By Product
14.3.2. By Application
14.3.3. By End Use
14.4. Country
14.4.1. India
14.4.2.China
14.4.3.South Korea
14.4.4.Japan
14.4.5.Rest of APAC
15.MIDDLE EAST AND AFRICA PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE & FORECAST 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1.By Product
15.3.2.By Application
15.3.3.By End Use
15.4.Country
15.4.1. Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4.South Africa
15.4.5.Rest of Middle East and Africa
16. LATIN AMERICA PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE & FORECAST 2022A-2032F
16.1.Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product
16.3.2.By Application
16.3.3.By End Use
16.4.Country
16.4.1.Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1.Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1. Octapharma AG
18.1.1.Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3.Market Share
18.1.4.4.Recent News & Development (Last 3 Yrs.)
18.1.4.5.Executive Team
18.2.Grifols S.A.
18.3.Novo Nordisk
18.4.CSL Behring GmbH
18.5.Kedrion Biopharma Inc.
18.6.China Biologic Products Holdings, Inc.
18.7.Shire Plc
18.8.Sanquin
18.9.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
1.1. Regional Market Share
1.2.Business Trends
1.3.Prothrombin Complex Concentrate Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1.Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4.Primary Research
2.5.Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1.Market Definition
3.2.Prothrombin Complex Concentrate Market: COVID-19 Impact
3.3. Key Segmentations
3.4.Key Developments
3.5.Allied Industry Data
4. PROTHROMBIN COMPLEX CONCENTRATE MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2.COVID-19 overview on world economy
4.3.Industry ecosystem Channel analysis
4.4.Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7. MARKET DYNAMICS
7.1.Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4.Market Restraints
7.5. Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1.Porters Five Forces
9.2. PEST Analysis
9.2.1.Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10.PROTHROMBIN COMPLEX CONCENTRATE MARKET
10.1.Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2.Key Findings
11.3.Market Segmentation
11.3.1. By Product
11.3.1.1. 3-Factor PCC
11.3.1.1.1.By Value (USD Million) 2022-2032F
11.3.1.1.2. Market Share (%) 2022-2032F
11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.2.4-Factor PCC
11.3.1.2.1. By Value (USD Million) 2022-2032F
11.3.1.2.2.Market Share (%) 2022-2032F
11.3.1.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2. By Application
11.3.2.1.Congenital Coagulation Factor Deficiency
11.3.2.1.1. By Value (USD Million) 2022-2032F
11.3.2.1.2.Market Share (%) 2022-2032F
11.3.2.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Acquired Coagulation Factor Deficiency
11.3.2.2.1.By Value (USD Million) 2022-2032F
11.3.2.2.2. Market Share (%) 2022-2032F
11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.By End-Use
11.3.3.1.Hospitals
11.3.3.1.1. By Value (USD Million) 2022-2032F
11.3.3.1.2.Market Share (%) 2022-2032F
11.3.3.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Ambulatory Surgical Centres
11.3.3.2.1.By Value (USD Million) 2022-2032F
11.3.3.2.2. Market Share (%) 2022-2032F
11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Specialty Clinics
11.3.3.3.1.By Value (USD Million) 2022-2032F
11.3.3.3.2. Market Share (%) 2022-2032F
11.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.4. Others
11.3.3.4.1.By Value (USD Million) 2022-2032F
11.3.3.4.2. Market Share (%) 2022-2032F
11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
12.NORTH AMERICA PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE & FORECAST 2022A-2032F
12.1.Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product
12.3.2.By Application
12.3.3.By End Use
12.4. Country
12.4.1. United States
12.4.2.Canada
13.EUROPE PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE & FORECAST 2022A-2032F
13.1.Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1.By Product
13.3.2.By Application
13.3.3.By End Use
13.4.Country
13.4.1. Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4.Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14.ASIA PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3.Market Segmentation
14.3.1.By Product
14.3.2. By Application
14.3.3. By End Use
14.4. Country
14.4.1. India
14.4.2.China
14.4.3.South Korea
14.4.4.Japan
14.4.5.Rest of APAC
15.MIDDLE EAST AND AFRICA PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE & FORECAST 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1.By Product
15.3.2.By Application
15.3.3.By End Use
15.4.Country
15.4.1. Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4.South Africa
15.4.5.Rest of Middle East and Africa
16. LATIN AMERICA PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE & FORECAST 2022A-2032F
16.1.Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product
16.3.2.By Application
16.3.3.By End Use
16.4.Country
16.4.1.Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1.Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1. Octapharma AG
18.1.1.Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3.Market Share
18.1.4.4.Recent News & Development (Last 3 Yrs.)
18.1.4.5.Executive Team
18.2.Grifols S.A.
18.3.Novo Nordisk
18.4.CSL Behring GmbH
18.5.Kedrion Biopharma Inc.
18.6.China Biologic Products Holdings, Inc.
18.7.Shire Plc
18.8.Sanquin
18.9.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
